Loading...

Recent News

Home/Recent News

Germany Paves the Way for Reimbursement of Digital Health Care Apps

In Germany, doctors could potentially be prescribing health apps as medicines as early as 2020. This is one of the main objectives of the draft bill on the “Law for better provision through digitalization and innovation”, which is expected to be approved by the parliament early November.

By |2019-10-31T16:03:50-04:00October 24th, 2019|Recent News|0 Comments

Medical Disposables & Consumables Players Face Challenge of Government-Initiated Price Cuts in China

When the Chinese government started to slash the drug prices in 2018, we knew that it was only a matter of time before medical consumables would be affected.

By |2019-10-24T15:48:17-04:00September 11th, 2019|Recent News|Comments Off on Medical Disposables & Consumables Players Face Challenge of Government-Initiated Price Cuts in China

Possibility for Examination to be Included in the SHI Fee Scale Brings More Certainty for Reimbursement for New Diagnostics in Germany

In the past, the inclusion of new diagnostic tests in the EBM was not transparent, with unclear timelines and requirements and manufacturers were unable to...

By |2019-09-11T15:49:35-04:00September 11th, 2019|Recent News|Comments Off on Possibility for Examination to be Included in the SHI Fee Scale Brings More Certainty for Reimbursement for New Diagnostics in Germany

Escalated DRG Payment Model Pilot in China Expected to Pose a Genuine Threat to Innovators

As a critical element of accelerating the healthcare payment reform, the pilot of Diagnosis Related Groups in 30 major cities across China was officially announced in June by state administrations including...

By |2019-09-11T14:48:58-04:00September 11th, 2019|Recent News|Comments Off on Escalated DRG Payment Model Pilot in China Expected to Pose a Genuine Threat to Innovators

First Meeting of the Italian Regional Purchasing Centers

Quality is not anymore limited to the functional and esthetic products features and its handling use. The attention is now focused on the commercialization phase, innovative and efficacy features, profitability and usability of instruction for final users, as well as Eco-friendly features...

By |2019-09-11T14:49:14-04:00June 25th, 2019|Recent News|Comments Off on First Meeting of the Italian Regional Purchasing Centers

New Independent Medical Review Board for Germany

For medical device and diagnostic innovators, a planned organizational change in review boards for Germany’s Statutory Health Insurance (SHI) could lead to new opportunities for market access of their products.

By |2019-09-11T14:49:42-04:00April 1st, 2019|Recent News|Comments Off on New Independent Medical Review Board for Germany

Winter Has Come – Aggressive National Programs To Drive Down Drug Costs

China: 2018 was another eventful year for the pharmaceutical industry, highlighted by the Chinese government’s radical attempts to slash drug prices by the annual national drug price negotiation and along with the introduction of a national procurement program.

By |2019-09-11T14:48:29-04:00January 31st, 2019|Recent News|Comments Off on Winter Has Come – Aggressive National Programs To Drive Down Drug Costs

The Evolution of Medical Device Procurement in Italy

Assobiomedica, the body representing the medical device sector in Italy, published an update to the report ‘Public Policies for the Purchase of Medical Devices’ in October 2018. Boston healthcare outline procurement trend in the Italian reimbursement environment.

By |2019-09-11T15:21:31-04:00January 31st, 2019|Recent News|Comments Off on The Evolution of Medical Device Procurement in Italy

Defining the value of innovative treatment methods in Germany

A recent proposal by Jens Spahn, Federal Minister for Health in Germany, would limit the decision-making power of the Joint Federal Committee (G-BA) and lead to new evidence approaches for healthcare decision making.

By |2019-09-11T15:22:46-04:00January 31st, 2019|Recent News|Comments Off on Defining the value of innovative treatment methods in Germany

FDA Issues New Draft Guidance on Class Labeling of Companion Diagnostics

Earlier this month, the Food and Drug Administration announced a new draft guidance for companion diagnostics. The guidance describes considerations for the development and labeling of companion diagnostics to support the indicated uses of multiple therapeutic oncology products.

By |2019-09-11T15:23:59-04:00December 18th, 2018|Recent News|Comments Off on FDA Issues New Draft Guidance on Class Labeling of Companion Diagnostics